99
Views
7
CrossRef citations to date
0
Altmetric
Special Report

Development of vaccines to prevent malaria in pregnant women: WHO MALVAC meeting report

, , , , &
Pages 1271-1280 | Published online: 09 Jan 2014

References

  • Desai M, ter Kuile FO, Nosten F et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect. Dis.7(2), 93–104 (2007).
  • Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med.7(1), e1000221 (2010).
  • Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am. J. Trop. Med. Hyg.64(Suppl. 1–2), 28–35 (2001).
  • Guyatt HL, Snow RW. Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin. Microbiol. Rev.17(4), 760–769, table of contents (2004).
  • Brabin BJ, Romagosa C, Abdelgalil S et al. The sick placenta-the role of malaria. Placenta25(5), 359–378 (2004).
  • Ismail MR, Ordi J, Menendez C et al. Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum. Pathol.31(1), 85–93 (2000).
  • Brabin B, Verhoeff F. The contribution of malaria. In: Maternal Morbidity and Mortality. Maclean AB, Nielson J (Eds). Royal College of Obstetricians and Gynaecologists, London, UK, 65–78 (2002).
  • Menendez C, Romagosa C, Ismail MR et al. An autopsy study of maternal mortality in Mozambique: the contribution of infectious diseases. PLoS Med.5(2), e44 (2008).
  • Diagne N, Rogier C, Sokhna CS et al. Increased susceptibility to malaria during the early postpartum period. N. Engl. J. Med.343(9), 598–603 (2000).
  • Ramharter M, Grobusch MP, Kiessling G et al. Clinical and parasitological characteristics of puerperal malaria. J. Infect. Dis.191(6), 1005–1009 (2005).
  • Dicko A, Mantel C, Thera MA et al. Risk factors for malaria infection and anemia for pregnant women in the Sahel area of Bandiagara, Mali. Acta. Trop.89(1), 17–23 (2003).
  • Rogerson SJ, van den Broek NR, Chaluluka E, Qongwane C, Mhango CG, Molyneux ME. Malaria and anemia in antenatal women in Blantyre, Malawi: a twelve-month survey. Am. J. Trop. Med. Hyg.62(3), 335–340 (2000).
  • Saute F, Menendez C, Mayor A et al. Malaria in pregnancy in rural Mozambique: the role of parity, submicroscopic and multiple Plasmodium falciparum infections. Trop. Med. Int. Health7(1), 19–28 (2002).
  • Walker-Abbey A, Djokam RR, Eno A et al. Malaria in pregnant Cameroonian women: the effect of age and gravidity on submicroscopic and mixed-species infections and multiple parasite genotypes. Am. J. Trop. Med. Hyg.72(3), 229–235 (2005).
  • Steketee RW, Wirima JJ, Slutsker L, Breman JG, Heymann DL. Comparability of treatment groups and risk factors for parasitemia at the first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural Malawi. Am. J. Trop. Med. Hyg.55(Suppl. 1), 17–23 (1996).
  • Leenstra T, ter Kuile FO, Kariuki SK et al. Dehydroepiandrosterone sulfate levels associated with decreased malaria parasite density and increased hemoglobin concentration in pubertal girls from western Kenya. J. Infect. Dis.188(2), 297–304 (2003).
  • Menendez C. Malaria during pregnancy: a priority area of malaria research and control. Parasitol. Today11(5), 178–183 (1995).
  • Rogerson SJ, Hviid L, Duffy PE, Leke RF, Taylor DW. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect. Dis.7(2), 105–117 (2007).
  • Serra-Casas E, Menendez C, Bardaji A et al. The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes. J. Infect. Dis.201(1), 123–131 (2009).
  • Garner P, Gulmezoglu AM. Drugs for preventing malaria in pregnant women. Cochrane Database Syst. Rev. (4), CD000169 (2006).
  • Greenwood BM, Fidock DA, Kyle DE et al. Malaria: progress, perils, and prospects for eradication. J. Clin. Invest.118(4), 1266–1276 (2008).
  • Granja AC, Machungo F, Gomes A, Bergstrom S, Brabin B. Malaria-related maternal mortality in urban Mozambique. Ann. Trop. Med. Parasitol.92(3), 257–263 (1998).
  • Romagosa C, Ordi J, Saute F et al. Seasonal variations in maternal mortality in Maputo, Mozambique: the role of malaria. Trop. Med. Int. Health.12(1), 62–67 (2007).
  • Cottrell G, Mary JY, Barro D, Cot M. Is malarial placental infection related to peripheral infection at any time of pregnancy? Am. J. Trop. Med. Hyg.73(6), 1112–1118 (2005).
  • Brabin BJ, Agbaje SO, Ahmed Y, Briggs ND. A birthweight nomogram for Africa, as a malaria-control indicator. Ann. Trop. Med. Parasitol.93(Suppl. 1), S43–S57 (1999).
  • Fischer PR. Congenital malaria: an African survey. Clin. Pediatr. (Phila.)36(7), 411–413 (1997).
  • van Geertruyden JP, Thomas F, Erhart A, D’Alessandro U. The contribution of malaria in pregnancy to perinatal mortality. Am. J. Trop. Med. Hyg.71(Suppl. 2), 35–40 (2004).
  • Gamble C, Ekwaru JP, ter Kuile FO. Insecticide-treated nets for preventing malaria in pregnancy. Cochrane Database Syst. Rev. (2), CD003755 (2006).
  • Menendez C, Bardaji A, Sigauque B et al. Malaria prevention with IPTp during pregnancy reduces neonatal mortality. PLoS One5(2), e9438 (2010).
  • Reed SC, Wirima JJ, Steketee RW. Risk factors for anemia in young children in rural Malawi. Am. J. Trop. Med. Hyg.51(2), 170–174 (1994).
  • Schwarz NG, Adegnika AA, Breitling LP et al. Placental malaria increases malaria risk in the first 30 months of life. Clin. Infect. Dis.47(8), 1017–1025 (2008).
  • Mutabingwa TK, Bolla MC, Li JL et al. Maternal malaria and gravidity interact to modify infant susceptibility to malaria. PLoS Med.2(12), e407 (2005).
  • Menendez C, Ordi J, Ismail MR et al. The impact of placental malaria on gestational age and birth weight. J. Infect. Dis.181(5), 1740–1745 (2000).
  • ter Kuile FO, Parise ME, Verhoeff FH et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am. J. Trop. Med. Hyg.71(Suppl. 2), 41–54 (2004).
  • Naniche D, Bardaji A, Lahuerta M et al. Impact of maternal human immunodeficiency virus infection on birth outcomes and infant survival in rural Mozambique. Am. J. Trop. Med. Hyg.80(5), 870–876 (2009).
  • Mwapasa V, Rogerson SJ, Molyneux ME et al. The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. AIDS18(7), 1051–1059 (2004).
  • Inion I, Mwanyumba F, Gaillard P et al. Placental malaria and perinatal transmission of human immunodeficiency virus type 1. J. Infect. Dis.188(11), 1675–1678 (2003).
  • Brahmbhatt H, Sullivan D, Kigozi G et al. Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality. J. Acquir. Immune. Defic. Syndr.47(4), 472–476 (2008).
  • World Health Organization (WHO). A strategic framework for malaria prevention and control during pregnancy in the African region: report AFR/MAL/04/01. Brazzaville, Democratic Republic of Congo: WHO Regional Office for Africa (Ed.). (2006).
  • WHO. WHO Guidelines for the Treatment of Malaria. World Health Organization, Geneva, Switzerland (2010).
  • Ordi J, Ismail MR, Ventura PJ et al. Massive chronic intervillositis of the placenta associated with malaria infection. Am. J. Surg. Pathol.22(8), 1006–1011 (1998).
  • Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science272(5267), 1502–1504 (1996).
  • Baruch DI, Pasloske BL, Singh HB et al. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell82, 77–87 (1995).
  • Salanti A, Staalsoe T, Lavstsen T et al. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol. Microbiol.49, 179–191 (2003).
  • Magistrado P, Salanti A, Tuikue Ndam NG et al. VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes. J. Infect. Dis.198, 1071–1074 (2008).
  • Srivastava A, Gangnard SP, Round A et al. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proc. Natl Acad. Sci. USA107(11), 4884–4889 (2010).
  • Nielsen MA, Pinto VV, Resende M et al. Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites using single domains of VAR2CSA. Infect. Immun.2482–2487 (2009).
  • Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, Hviid L. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet363(9405), 283–289 (2004).
  • Duffy PE, Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect. Immun.71(11), 6620–6623 (2003).
  • Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE. Maternal antibodies block malaria. Nature395(6705), 851–852 (1998).
  • Menendez C, Todd J, Alonso PL, Lulat S, Francis N, Greenwood BM. Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae. J. Trop. Med. Hyg.97(4), 244–248 (1994).
  • Beeson JG, Brown GV, Molyneux ME, Mhango C, Dzinjalamala F, Rogerson SJ. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J. Infect. Dis.180(2), 464–472 (1999).
  • Rogerson SJ, Beeson JG, Mhango CG, Dzinjalamala FK, Molyneux ME. Plasmodium falciparum rosette formation is uncommon in isolates from pregnant women. Infect. Immun.68(1), 391–393 (2000).
  • Fried M, Hixson KK, Anderson L, Ogata Y, Mutabingwa TK, Duffy PE. The distinct proteome of placental malaria parasites. Mol. Biochem. Parasitol.155(1), 57–65 (2007).
  • Fried M, Wendler JP, Mutabingwa TK, Duffy PE. Mass spectrometric analysis of Plasmodium falciparum erythrocyte membrane protein-1 variants expressed by placental malaria parasites. Proteomics4(4), 1086–1093 (2004).
  • Francis SE, Malkov VA, Oleinikov AV et al. Six genes are preferentially transcribed by the circulating and sequestered forms of Plasmodium falciparum parasites that infect pregnant women. Infect. Immun.75(10), 4838–4850 (2007).
  • Tuikue Ndam N, Bischoff E, Proux C et al.Plasmodium falciparum transcriptome analysis reveals pregnancy malaria associated gene expression. PLoS One3(3), e1855 (2008).
  • Ricke CH, Staalsoe T, Koram K et al. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A. J. Immunol.165(6), 3309–3316 (2000).
  • Ataide R, Hasang W, Wilson DW et al. Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria. PLoS One5(5), e10807 (2010).
  • Cox SE, Staalsoe T, Arthur P et al. Rapid acquisition of isolate-specific antibodies to chondroitin sulfate A-adherent Plasmodium falciparum isolates in Ghanaian primigravidae. Infect. Immun.73(5), 2841–2847 (2005).
  • Fievet N, Le Hesran JY, Cottrell G et al. Acquisition of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes during pregnancy. Infect. Genet. Evol.6(6), 459–463 (2006).
  • Rasheed FN, Bulmer JN, Dunn DT et al. Suppressed peripheral and placental blood lymphoproliferative responses in first pregnancies: relevance to malaria. Am. J. Trop. Med. Hyg.48(2), 154–160 (1993).
  • Riley EM, Schneider G, Sambou I, Greenwood BM. Suppression of cell-mediated immune responses to malaria antigens in pregnant Gambian women. Am. J. Trop. Med. Hyg.40(2), 141–144 (1989).
  • Rasheed FN. Maternal infections influence infection susceptibility in childhood. Med. Hypotheses42(2), 76–80 (1994).
  • Malhotra I, Dent A, Mungai P et al. Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya. PLoS Med.6(7), e1000116 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.